Bilirubin neurotoxicity is associated with proteasome inhibition
Hongbiao Huang(Harbin Institute of Technology), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cited by 37
Related Papers
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
|Oncotarget|2014|170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
|Cell Death and Disease|2017|118
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
|Journal of Experimental & Clinical Cancer Research|2019|102
Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
|Journal of Experimental & Clinical Cancer Research|2019|101
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
|Cell Death and Disease|2017|97